Cargando…
mGlu(1) potentiation enhances prelimbic somatostatin interneuron activity to rescue schizophrenia-like physiological and cognitive deficits
Evidence for prefrontal cortical (PFC) GABAergic dysfunction is one of the most consistent findings in schizophrenia and may contribute to cognitive deficits. Recent studies suggest that the mGlu(1) subtype of metabotropic glutamate receptor regulates cortical inhibition; however, understanding the...
Autores principales: | Maksymetz, James, Byun, Nellie E., Luessen, Deborah J., Li, Brianna, Barry, Robert L., Gore, John C., Niswender, Colleen M., Lindsley, Craig W., Joffe, Max E., Conn, P. Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628371/ https://www.ncbi.nlm.nih.gov/pubmed/34731619 http://dx.doi.org/10.1016/j.celrep.2021.109950 |
Ejemplares similares
-
mGlu(5) Positive Allosteric Modulators Facilitate
Long-Term Potentiation via Disinhibition Mediated by mGlu(5)-Endocannabinoid Signaling
por: Xiang, Zixiu, et al.
Publicado: (2019) -
Discovery of a Novel Chemical Class of mGlu(5) Allosteric Ligands with Distinct Modes of Pharmacology
por: Hammond, Alexis S., et al.
Publicado: (2010) -
Differential activity of mGlu(7) allosteric modulators provides evidence for mGlu(7/8) heterodimers at hippocampal Schaffer collateral-CA1 synapses
por: Lin, Xin, et al.
Publicado: (2022) -
Challenges in the Discovery and Optimization of mGlu(2/4) Heterodimer Positive Allosteric Modulators
por: Fulton, Mark Gallant, et al.
Publicado: (2019) -
The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies
por: Senter, Rebecca K., et al.
Publicado: (2016)